Related Experiment Video
Updated: Aug 5, 2026

09:02
Cortical Bone Assessment Using Ultrasonic Guided Waves: A Reproducibility Study in a Healthy Population
Published on: January 31, 2025
Early Identification of Low Bone Density Risk Using a Radiofrequency Echographic Multi Spectrometry-Based Prediction
Elena Bischoff1,2, Stoyanka Vladeva1, Nikola Kirilov3
1Department of Health Care, Faculty of Medicine, Trakia University, 6000 Stara Zagora, Bulgaria.
Life (Basel, Switzerland)
|July 28, 2026
Summary
This study developed a model using clinical data and Radiofrequency Echographic Multi Spectrometry (REMS) to detect low bone density in women. The model effectively identifies individuals at risk, aiding in early osteoporosis prevention.
Area of Science:
- Osteoporosis research
- Medical diagnostics
- Bone health
Background:
- Osteoporosis is a significant public health concern, marked by decreased bone mineral density (BMD) and elevated fracture risk.
- Early detection of low bone density is crucial for effective osteoporosis prevention strategies.
Purpose of the Study:
- To assess a multivariable logistic regression model for identifying low bone density in women.
- The model integrates clinical factors with Radiofrequency Echographic Multi Spectrometry (REMS)-derived parameters.
Main Methods:
- A cohort of 324 women undergoing REMS assessment of the hip and lumbar spine was analyzed.
- Binary logistic regression identified independent predictors of low BMD (T-score < -1 SD).
- Model performance was evaluated using odds ratios, chi-square tests, pseudo-R², and classification accuracy.
Main Results:
- Age, menopausal status, body mass index (BMI), and basal metabolic rate (BMR) were identified as independent factors associated with low BMD.
- Advancing age and menopause increased the likelihood of low bone density.
- Higher BMI and BMR showed an inverse association with low bone density.
Conclusions:
- A logistic regression model combining clinical and REMS data effectively identifies women with low bone density.
- This approach supports enhanced, individualized risk stratification for osteoporosis in clinical practice.
